Unlock NIH's West Nile Antibodies: From Lab to Life-Saving Treatments
Published Date: 4/22/2026
Notice
Summary
The National Institutes of Health is offering a cool new invention—special antibodies that fight West Nile Virus—for companies to license and develop into treatments or tests. This means businesses can jump on this opportunity to create medicines or diagnostics, with some foreign patent protections included. Interested parties should act soon and may need to sign a confidentiality agreement to get all the details.
Analyzed Economic Effects
5 provisions identified: 3 benefits, 2 costs, 0 mixed.
Government Tech Available for Licensing
The NIH (NIAID) is offering human monoclonal antibodies against West Nile virus for commercial licensing in accordance with 35 U.S.C. 209 and 37 CFR part 404. The technology is referenced as HHS Ref. No. E-200-2024-0, with a U.S. provisional patent filed July 31, 2024 and PCT application filed July 30, 2025.
Foreign Patent Coverage Offered
The notice states that foreign patent applications are filed on selected inventions to extend market coverage for companies and that these foreign filings may also be available for licensing. The PCT Patent Application No. PCT/US2025/039922 was filed on July 30, 2025.
Technology Is at Pre-Clinical Stage
The development stage of the NIH antibodies against West Nile virus is listed as 'Pre-Clinical.' This indicates the invention has not yet reached clinical testing in humans.
Confidentiality Agreement Required for Details
A signed Confidential Disclosure Agreement (CDA) is required to receive copies of unpublished information related to the invention. Contact Brian Bailey at the NIAID Technology Transfer Office for licensing details.
NIAID Seeks Development Collaborators
NIAID is seeking statements of capability or interest from parties for collaborative research to further develop, evaluate, or commercialize the West Nile virus antibody technology. Interested parties are instructed to contact Brian Bailey for collaboration opportunities.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-09808 — Government Owned Inventions Available for License: Synergistic Interactions for Improved Cancer Treatment
The National Cancer Institute is offering a cool new cancer treatment invention called hetIL-15 that works better when combined with other drugs like Fenofibrate and quizartinib. This combo could help patients by making immune cells stronger and safer, potentially beating tough cancers like breast and pancreatic tumors. Researchers and companies interested in developing or licensing this tech should act soon to join the fight against cancer and bring these treatments to life.
2026-09292 — Government Owned Inventions Available for License: Enhanced Tumor Reactivity of T Cells Lacking SIT1, LAX1 or TRAT1
The government has a cool new discovery that makes certain immune cells, called T cells, better at fighting cancer by turning off some ‘brakes’ inside them. This could lead to stronger treatments for cancer, infections, and autoimmune diseases. Companies interested in developing this technology can license it now, potentially speeding up new, powerful therapies and boosting health outcomes.
2026-08606 — Center for Scientific Review; Notice of Closed Meetings
The NIH’s Center for Scientific Review is holding several closed virtual meetings in June 2026 to review and evaluate grant applications related to aging, genetics, neurodegeneration, and pediatric critical care. These meetings protect sensitive info like trade secrets and personal data, so they’re not open to the public. Researchers applying for grants should note these dates as they impact funding decisions and the review process timeline.
2026-08638 — Center for Scientific Review; Notice of Closed Meetings
The NIH’s Center for Scientific Review is holding several closed virtual meetings in June 2026 to review and decide on grant applications. These meetings affect researchers seeking funding for brain, behavior, and imaging studies, keeping sensitive info private. No new costs or deadlines are announced, but these reviews shape which projects get money next.
2026-08456 — Proposed Collection; 60-Day Comment Request; NIH Office of Intramural Training & Education-Application, Registration, and Alumni Systems Office of the Director
The NIH Office of Intramural Training & Education wants your thoughts on updating their application, registration, and alumni systems. This affects students, trainees, and alumni who use these systems, aiming to make things smoother and less time-consuming. You’ve got 60 days to share your ideas before they finalize the changes—no extra costs involved, just better tech and less hassle!
2026-08461 — Submission for OMB Review; 30-Day Comment Request Application and Impact of Clinical Research Training on Healthcare Professionals in Academia and Clinical Research (Office of the Director)
The NIH is asking for public feedback on a survey about how clinical research training helps healthcare pros in schools and labs. This is a quick 30-day chance to share your thoughts before June 1, 2026. No big costs or changes yet—just making sure the survey is clear and useful for everyone involved.
Previous / Next Documents
Previous: 2026-07768 — Takes of Marine Mammals Incidental to Specified Activities; Taking Marine Mammals Incidental to the Francis Scott Key Bridge Rebuild Project in Baltimore, Maryland
The government is planning to rebuild the Francis Scott Key Bridge in Baltimore, and this work might accidentally disturb some local marine mammals like dolphins and seals. They’re asking for public comments before approving special permits that let the project continue while protecting these animals. The decision and possible renewals will happen soon, with comments due by May 22, 2026.
Next: 2026-07770 — Government-Owned Inventions; Availability for Licensing
The National Institutes of Health is offering licenses for new antibodies that fight West Nile virus, a serious illness spread by mosquitoes. These antibodies could lead to treatments or preventions, especially for people at high risk. Companies interested in developing these inventions can start licensing now, with some international protections available too.